SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-22-000076
Filing Date
2022-11-09
Accepted
2022-11-09 17:07:04
Documents
94
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20220930.htm   iXBRL 10-Q 1794813
2 EX-31.1 supn-20220930x10qxex311.htm EX-31.1 9759
3 EX-31.2 supn-20220930x10qxex312.htm EX-31.2 10093
4 EX-32.1 supn-20220930x10qxex321.htm EX-32.1 5022
5 EX-32.2 supn-20220930x10qxex322.htm EX-32.2 5043
  Complete submission text file 0001356576-22-000076.txt   9049059

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20220930.xsd EX-101.SCH 59202
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20220930_cal.xml EX-101.CAL 106275
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20220930_def.xml EX-101.DEF 315160
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20220930_lab.xml EX-101.LAB 717817
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20220930_pre.xml EX-101.PRE 499120
88 EXTRACTED XBRL INSTANCE DOCUMENT supn-20220930_htm.xml XML 1665684
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 221373622
SIC: 2834 Pharmaceutical Preparations